Cost-Effectiveness of Cardiovascular, Obesity, and Diabetes Mellitus Drugs: Comparative Analysis of the United States and England.
作者信息
Cherla Avi, Renwick Matthew, Stefanini Giulio, Holmes David R, Mossialos Elias
机构信息
Department of Health Policy London School of Economics and Political Science London United Kingdom.
Humanitas Clinical and Research Center IRCCS Rozzano-Milan Italy.
出版信息
J Am Heart Assoc. 2020 Nov 3;9(21):e018281. doi: 10.1161/JAHA.120.018281. Epub 2020 Oct 30.
Abstract
摘要
相似文献
1
Cost-Effectiveness of Cardiovascular, Obesity, and Diabetes Mellitus Drugs: Comparative Analysis of the United States and England.心血管、肥胖及糖尿病药物的成本效益：美国与英国的比较分析
J Am Heart Assoc. 2020 Nov 3;9(21):e018281. doi: 10.1161/JAHA.120.018281. Epub 2020 Oct 30.
2
Economics of diabetes mellitus.糖尿病经济学
Nurs Clin North Am. 2006 Dec;41(4):499-511, v-vi. doi: 10.1016/j.cnur.2006.07.003.
3
Economic evaluations and diabetes.经济评估与糖尿病
Pharm Pract Manag Q. 1998 Jan;17(4):17-24.
4
Cost-effectiveness of sibutramine in the treatment of obesity.西布曲明治疗肥胖症的成本效益
Med Decis Making. 2004 Jan-Feb;24(1):9-19. doi: 10.1177/0272989X03261565.
5
Prescription drug use and costs among diabetic patients in primary health care practices in Germany.德国初级卫生保健机构中糖尿病患者的处方药使用情况及费用
Diabetes Care. 1998 Mar;21(3):389-97. doi: 10.2337/diacare.21.3.389.
6
Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom.英国治疗HBeAg阳性和HBeAg阴性慢性乙型肝炎的替代抗病毒策略的成本效益分析
Value Health. 2015 Sep;18(6):800-9. doi: 10.1016/j.jval.2015.05.007. Epub 2015 Jul 27.
7
Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).二甲双胍强化血糖控制在超重2型糖尿病患者中的成本效益分析（英国前瞻性糖尿病研究第51号）
Diabetologia. 2001 Mar;44(3):298-304. doi: 10.1007/s001250051617.
8
Diabetes drugs in England cost nearly £1bn last year.去年，英国的糖尿病药物花费近10亿英镑。
BMJ. 2016 Aug 4;354:i4324. doi: 10.1136/bmj.i4324.
9
Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS).阿托伐他汀用于2型糖尿病患者心血管疾病一级预防的成本效益：阿托伐他汀糖尿病协作研究（CARDS）结果
Diabetologia. 2007 Apr;50(4):733-40. doi: 10.1007/s00125-006-0561-4. Epub 2007 Jan 31.
10
Cost-effectiveness of Pembrolizumab in Second-line Advanced Bladder Cancer.帕博利珠单抗二线治疗晚期膀胱癌的成本效果分析。
Eur Urol. 2018 Jul;74(1):57-62. doi: 10.1016/j.eururo.2018.03.006. Epub 2018 Mar 22.
引用本文的文献
1
Pharmacoeconomic Aspects of Diabetes Mellitus: Outcomes and Analysis of Health Benefits Approach.糖尿病的药物经济学方面：健康效益方法的结果与分析
Curr Diabetes Rev. 2024;20(8):12-22. doi: 10.2174/0115733998246567230924134603.
Zotero 插件